Tongo-test
The Tongo-test enables migraine patients to receive effective specific therapy quickly and reliably. The form factor test resembles the rapid COVID-19 test but detects levels of CGRP, a pain marker protein. Migraine is the most common neurological disease and has a significant economic burden due to the disability of such individuals for the duration of attacks. Our development will allow us to systematise migraine (currently diagnosed clinically, i.e. based entirely on the expertise of the physician) and reliably identify CGRP-positive patients for whom specific treatments are created.
Biotechnology And National Health
Genetic engineering technologies
Past year (sept 2024 - sept 2024) - Scientific publication, research analysis, CustDev, elaboration of technical aspect, team building, know-how
Russian Federation
stepwise prescription of drugs (from ergot alkaloids to antidepressants). Thus, if one drug is ineffective, the next one is prescribed and so on until a drug with sufficient therapeutic effect is found. The main competitive advantages of the test system are the objectivity of the diagnosis and the speed of prescribing an effective drug. The combination of these two advantages gives birth to the third one - cheaper medical care. The algorithm presented by us allows us to minimise the negative consequences of the use of medicines. Moreover, both from side effects and from drug dependencies (for example, headache resulting from abuse of analgesics is extremely difficult to treat). At the moment there are no test systems in Russia that detect CGRP in tears. In the UK and USA, analogues are registered, used exclusively in clinical trials. 1) Non-invasiveness: the method minimises the risk of complications from the diagnostic procedure. It does not require additional consumables or complex medical manipulations. 2) Speed: this type of test gives results immediately, which allows you to make a diagnosis and determine treatment tactics at the first appointment. 3) Simplicity and independence: allows the doctor or patient to get a result within a few minutes, which does not depend on the experience and skills of the person conducting the test. It does not require recourse to expensive laboratory facilities. 4) Objectivity: the data obtained allows to judge with a high degree of probability the subtype of migraine, after which a targeted treatment will be prescribed.
N.A.
N.A.
